Prioritizing translational research is changing drug development for patients and doctors, for good

Photo by Edward Jenner from Pexels

Twelve years. That’s the average amount of time it takes for a viable therapeutic to make it from the research stage to approval for market. In that time, 2.4 million Americans will suffer the effects of severe acute pancreatitis, many of which can be long-lasting and debilitating. Roughly 240,000 of these patients will die as a result of the illness. This is from just one potentially treatable disease.

With more Americans falling ill to preventable diseases each year, the pressure has never been greater for researchers and developers to find ways to create higher-quality therapeutics in less time to save and improve lives. Surprisingly, the way forward is not to change the approval process but to improve the research and development methods applied at each pipeline stage.

The logjam isn’t the approval process — it’s the methods

At first glance, it is easy to assume …

Read more
  • 0